Skip to content
Screener

Regeneron Pharmaceuticals REGN Share Repurchase Program - Amount Remaining

Share Repurchase Program - Amount Remaining at other companies

Amgen logo
AmgenAMGN
$6.8B0.0%

Other financials

Income statement

See full
Revenue$4.3B+16.7%
Operating income$1.3B+19.8%
Net income$1.3B-6.8%
EPS (diluted)$12.23-4.5%

Balance sheet

See full
Cash & equivalents$2.5B+22.3%
Total debt$2.7B+0.1%
Total equity$31.7B+5.9%
Total assets$41.7B+9.2%

Cash flow

See full
Operating cash flow$813.0M-29.0%
CapEx$240.2M+9.7%
Free cash flow$572.8M-38.1%

Valuation

See full
Market cap$80.75B+43.8%
Enterprise value$80.99B+42.5%
P/E18.7×+6.1×
P/S5.2×+1.2×

Profitability

See full
Gross margin94.9%—
Operating margin24.7%-2.3pp
Net margin27.9%-3.5pp
FCF margin24.2%-2.9pp

Returns & leverage

See full
Return on equity14%-1.3pp
Debt / equity0.1×0.0×
Current ratio3.3×-1.3×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1.

The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 6:52 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000872589-26-000025

As of June 30, 2026, $2.534 billion remained available for share repurchases under the Company's share repurchase programs.

Item 1. Financial Statements (unaudited)

FAQ

What is Regeneron Pharmaceuticals's share repurchase program - amount remaining?
Regeneron Pharmaceuticals (REGN) reported share repurchase program - amount remaining of $2.53B in Q2 2026.
How has Regeneron Pharmaceuticals's share repurchase program - amount remaining changed year-over-year?
Regeneron Pharmaceuticals's share repurchase program - amount remaining decreased by 10.0% year-over-year, from $2.81B to $2.53B.

Ask your AI about Regeneron Pharmaceuticals's share repurchase program - amount remaining.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude